{"id":"W2119750849","doi":"10.1093/annonc/mdv033","title":"A phase II study of SB939, a novel pan-histone deacetylase inhibitor, in patients with translocation-associated recurrent/metastatic sarcomas—NCIC-CTG IND 200","year":2015,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Ottawa; University of Toronto; Mount Sinai Hospital; University of Calgary; McGill University; Princess Margaret Cancer Centre; BC Cancer Agency; Juravinski Cancer Centre; Alberta Cancer Foundation; University of Alberta","funders":"National Cancer Institute; Canadian Cancer Society Research Institute","keywords":"Medicine; Chromosomal translocation; Cancer research; Population; Histone deacetylase 2; Internal medicine; Oncology; Fusion gene; PTEN; PI3K/AKT/mTOR pathway; Histone deacetylase; Histone; Apoptosis; Biology; Genetics; Gene","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009813663,0.001385194,0.002036298,0.0004945634,0.0004755992,0.0008760318,0.0009889586,0.001059779,0.003172019],"category_scores_gemma":[0.0005202405,0.0005393879,0.001469735,0.0004995605,0.0008522568,0.0007088404,0.0003067685,0.00333575,0.0009080263],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009860148,"about_ca_system_score_gemma":0.001472835,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003193143,"about_ca_topic_score_gemma":0.009800187,"domain_scores_codex":[0.9997275,0.0001020426,0.00001359347,0.00005286724,0.00002512771,0.00007879315],"domain_scores_gemma":[0.9996196,0.00006040662,0.00004055517,0.00003391317,0.00002127073,0.0002242994],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5338857,0.07804681,0.01360937,0.0009719915,0.00326205,0.0006916129,0.0005718677,0.006711335,0.1152856,0.000808771,0.01033248,0.2358223],"study_design_scores_gemma":[0.4072263,0.5508474,0.02280187,0.00005195777,0.001077076,0.0007745164,0.0001798853,0.003036882,0.007095236,0.0003887142,0.006456126,0.00006410479],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9899815,0.002924186,0.0007911252,0.0007910464,0.0001909236,0.001286533,0.001201421,0.0001533219,0.002679917],"genre_scores_gemma":[0.9869576,0.00286472,0.001763381,0.0009036947,0.0001255966,0.00100742,0.003255346,0.0000468493,0.003075504],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003193143,"threshold_uncertainty_score":0.01061141,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07395527588728779,"score_gpt":0.4008257079399833,"score_spread":0.3268704320526956,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}